https://ift.tt/2CWhjOp support@endlesssupplies.biz (Endless Supplies .Biz) October 21, 2018 at 10:01AM
Sunday, October 21, 2018
AstraZeneca's Lynparza shown to put brakes on ovarian cancer
An AstraZeneca drug that blocks a cancer cell's ability to repair its genetic code greatly reduced the risk of ovarian cancer worsening in a phase III trial, underpinning its lead against two U.S. rivals in the same class.
https://ift.tt/2CWhjOp support@endlesssupplies.biz (Endless Supplies .Biz) October 21, 2018 at 10:01AM
https://ift.tt/2CWhjOp support@endlesssupplies.biz (Endless Supplies .Biz) October 21, 2018 at 10:01AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment